医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| 4-(6-(甲氧羰基)吡啶-3-基)哌嗪-1-羧酸叔丁酯 | tert-butyl 4-(6-(methoxycarbonyl)pyridin-3-yl)piperazine-1-carboxylate | 1354355-85-3 | C16H23N3O4 |
| 4-(6-(7-环戊基-6-(二甲基甲酰基)-7H-吡咯并[2,3-D]嘧啶-2-基氨基吡啶-3-基)哌嗪-1-羧酸叔丁酯 | tert-butyl 4-(6-((7-cyclopentyl-6-(dimethylcarbamoyl)-7H-pyrrolo[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carboxylate | 1374639-78-7 | C28H38N8O3 |
| 4-(5-辛基-2-嘧啶基)苯基庚酸酯 | 1-heptanoyloxy-4-(5-octyl-pyrimidin-2-yl)-benzene | 58415-91-1 | C25H36N2O2 |
| 4-(5-碘-4-嘧啶)吗啉 | 4-(5-iodopyrimidin-4-yl)morpholine | 1356055-09-8 | C8H10IN3O |
| 4-(5-硝基吡啶-2-基)苯甲酸 | 4-(5-nitro-2-pyridinyl)benzoic acid | 223127-49-9 | C12H8N2O4 |
| 4-(5-硝基-吡啶-2-基氧基)-哌啶-1-羧酸叔丁酯 | tert-butyl 4-((5-nitropyridin-2-yl)oxy)piperidine-1-carboxylate | 346665-40-5 | C15H21N3O5 |
| 4-(5-甲基吡啶-2-基)苯甲酸 | 4-(5-methylpyridin-2-yl)benzoic acid | 845826-92-8 | C13H11NO2 |
| 4-(5-甲基-苯并噁唑-2-基)-苯胺 | 5-methyl-2-(4-aminophenyl)benzo[d]oxazole | 22501-77-5 | C14H12N2O |
| 4-(5-甲基-3-苯基异噁唑-4-基)苯磺酰氯 | 4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonyl chloride | 509074-26-4 | C16H12ClNO3S |
| 4-(5-溴砒啶-3-基磺酰)吗啉 | 4-(5-bromopyridin-3-ylsulfonyl)morpholine | 889676-35-1 | C9H11BrN2O3S |
| 4-(5-溴吡啶-2-基)吗啉 | 5-bromo-2-(4-morpholinyl)pyridine | 200064-11-5 | C9H11BrN2O |
| 4-(5-溴-2-氯苄基)苯酚 | 4-(5-bromo-2-chlorobenzyl)phenol | 864070-18-8 | C13H10BrClO |
| 4-(5-氨基吡啶-2-基)哌嗪-1-羧酸叔丁酯 | 4-(5-aminopyridin-2-yl)piperazine-1-carboxylic acid tert-butyl ester | 119285-07-3 | C14H22N4O2 |
| 4-(5-异丙氧基-2-甲基-4-硝基-苯基)-吡啶 | 4-(5-isopropoxy-2-methyl-4-nitrophenyl)pyridine | 1032903-62-0 | C15H16N2O3 |
| 4-(5-嘧啶基)苯甲醛 | 4-(pyrimidin-5-yl)benzaldehyde | 198084-12-7 | C11H8N2O |
| 4-(5-嘧啶基)丁醛 | 4-(5-pyrimidyl)butyraldehyde | 260441-11-0 | C8H10N2O |
| 4-(5-三氟甲基-2-吡啶氧基)苄胺肟 | N-hydroxy-4-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzimidamide | 263161-34-8 | C13H10F3N3O2 |
| 4-(5-(三氟甲基)-1,2,4-恶二唑-3基)苯甲酸 | 4-[5-(trifluoromethyl)-1,2,4-oxadiazol-3-yl]benzoic acid | 340736-76-7 | C10H5F3N2O3 |
| 4-(4-苯氧基丁氧基)-7H-呋喃并[3,2-G][1]苯并吡喃-7-酮 | PAP-1 | 870653-45-5 | C21H18O5 |
| 4-(4-羧基苯基)哌嗪-1-羧酸叔丁酯 | 4-(4-(tert-butoxycarbonyl)piperazin-1-yl)benzoic acid | 162046-66-4 | C16H22N2O4 |
| 4-(4-羟基苯基)丁酸 | 4-(4-hydroxyphenyl)butanoic acid | 7021-11-6 | C10H12O3 |
| 4-(4-羟基联苯甲基)哌啶-1-氧代丁基-2,2-二甲基苯乙酸甲酯 | methyl 2-(4-(4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butanoyl)phenyl)-2-methylpropanoate | 154477-55-1 | C33H39NO4 |
| 4-(4-羟基哌啶-1-基)苯(甲)醛 | 4-(4-hydroxypiperidin-1-yl)benzaldehyde | 79421-44-6 | C12H15NO2 |
| 4-(4-碘-1H-吡唑-1-基)-1-哌啶羧酸叔丁酯 | tert-butyl 4-(4-iodo-1H-pyrazol-1-yl)piperidine-1-carboxylate | 877399-73-0 | C13H20IN3O2 |
| 4-(4-硝基苯氧基)四氢-1(2H)-吡啶羧酸叔丁酯 | tert-butyl 4-(4-nitrophenoxy)piperidine-1-carboxylate | 138227-62-0 | C16H22N2O5 |
| 4-(4-硝基苯氧基)吡啶 | 4-nitrophenyl-4-pyridyl ether | 4783-83-9 | C11H8N2O3 |
| 4-(4-硝基苯基)哌嗪-1-羧酸叔丁酯 | tert-butyl 4-(4-nitrophenyl)piperazine-1-carboxylate | 182618-86-6 | C15H21N3O4 |
| 4-(4-硝基苄基)吡啶 | 4-Nitrobenzylpyridin | 1083-48-3 | C12H10N2O2 |
| 4-(4-甲氧苯基)-6-三氟甲基嘧啶-2-胺 | 2-amino-4-(4-methoxyphenyl)-6-(trifluoromethyl)pyrimidine | 519056-51-0 | C12H10F3N3O |
| 4-(4-甲氧基苯基)哌嗪-1-甲酰胺 | 4-(4-Methoxyphenyl)piperazine-1-carboxamide | 89026-59-5 | C12H17N3O2 |
| 4-(4-甲氧基苯基)吡啶 | 4-(4-methoxylphenyl)pyridine | 5938-16-9 | C12H11NO |
| 4-(4-甲氧基苯基)-2,6-二甲基-1,4-二氢吡啶-3,5-二羧酸二甲酯 | 1,4-dihydro-2,6-dimethyl-4-(p-methoxyphenyl)pyridine-3,5-dicarboxylic acid dimethyl ester | 73257-47-3 | C18H21NO5 |
| 4-(4-甲基哌嗪-1-基甲基)苯胺 | 4-[(4-methyl-1-piperazinyl)methyl]aniline | 70261-82-4 | C12H19N3 |
| 4-(4-甲基哌嗪-1-基)苯甲腈 | 4-(4-methylpiperazin-1-yl)benzonitrile | 34334-28-6 | C12H15N3 |
| 4-(4-甲基哌嗪-1-基)-2-硝基苯甲酸叔丁酯 | tert-butyl 4-(4-methylpiperazin-1-yl)-2-nitrobenzoate | 942271-61-6 | C16H23N3O4 |
| 4-(4-甲基哌嗪-1-亚甲基)-3-三氟甲基-1-硝基苯 | 1-methyl-4-(4-nitro-2-(trifluoromethyl)benzyl)piperazine | 694499-24-6 | C13H16F3N3O2 |
| 4-(4-甲基哌嗪)苯胺 | 4-(4-Methyl-piperazino)-anilin | 16153-81-4 | C11H17N3 |
| 4-(4-甲基-哌嗪-1-基)-苯甲酸乙酯 | ethyl 4-(4-methylpiperazin-1-yl)benzoate | 773137-71-6 | C14H20N2O2 |
| 4-(4-甲基-1-哌嗪基)苯甲醇 | (4-(4-methylpiperazin-1-yl)phenyl)methanol | 342405-34-9 | C12H18N2O |
| 4-(4-甲基-1-哌嗪基)丁酸 | 4-(4-methyl-1-piperazinyl)butyric acid | 58077-68-2 | C9H18N2O2 |
| 4-(4-甲基-1-哌嗪基)-2-[(4-四氢吡喃基)(2,2,2-三氟乙酰基)氨基]苯甲酸三氟乙酸盐 | 4-(4-methylpiperazin-1-yl)-2-[tetrahydro-2H-pyran-4-yl-(2,2,2-trifluoroacetyl)amino]benzoic acid trifluoroacetate | 1034975-62-6 | C2HF3O2*C19H24F3N3O4 |
| 4-(4-溴苯基)四氢吡喃-4-醇 | 4-(4-bromophenyl)tetrahydro-2H-pyran-4-ol | 165119-46-0 | C11H13BrO2 |
| 4-(4-溴苯基)吡唑 | 4-(4-bromophenyl)-1H-pyrazole | 849021-16-5 | C9H7BrN2 |
| 4-(4-溴苯基)-2-苯基-6-吡啶-2-基嘧啶 | 4-(4-bromophenyl)-2-phenyl-6-(2-pyridyl)pyrimidine | 607739-87-7 | C21H14BrN3 |
| 4-(4-溴苯基)-2-甲基嘧啶 | 4-(4-Bromophenyl)-2-methylpyrimidine | 499785-50-1 | C11H9BrN2 |
| 4-(4-溴苯基)-2,6-二苯基嘧啶 | 4-(4-bromophenyl)-2,6-diphenylpyrimidine | 58536-46-2 | C22H15BrN2 |
| 4-(4-溴苯基)-1-(甲基磺酰基)哌啶 | 4-(4-bromophenyl)-1-(methylsulfonyl)piperidine | 622386-94-1 | C12H16BrNO2S |
| 4-(4-溴嘧啶-2-基)吗啉 | 4-(4-bromopyrimidin-2-yl)morpholine | 663194-10-3 | C8H10BrN3O |
| 4-(4-溴吡啶-2-基)哌嗪-1-羧酸叔丁酯 | tert-butyl 4-(4-bromopyridin-2-yl)piperazine-1-carboxylate | 1197294-80-6 | C14H20BrN3O2 |
| 4-(4-溴-苯基)-二苯并噻吩 | 4-(4-bromophenyl)dibenzothiophene | 530402-77-8 | C18H11BrS |